A Conversation with Rafik Bishara
After a long tenure at Eli Lilly and Company, Rafik Bishara, PhD, entered a new phase in his career: a globally recognized authority on how the transportation, storage and distribution practices of the global pharma industry are defined and regulated.
Specialty pharmacy accreditation — burden and benefit
What makes specialty pharmaceuticals ‘special’? Other than cost (the primary criterion), it is often the tangled combination of patients’ health and personal situations, comorbidities, and complex forms of drug delivery (often, infusion). This, in turn, calls for a greater number
The 2018 Pharma Cold Chain: more data leads to less risk
Pharma manufacturers have been able to deliver refrigerated products to patients almost since the time when mechanical refrigeration was invented—the BioPharma Cold Chain Sourcebook cites instructions from Parke, Davis & Co. in 1919 to keep smallpox vaccine refrigerated. Over the
Biopharma cold-chain market forecast
The 9th edition of Pharmaceutical Commerce’s Biopharma Cold Chain Sourcebook details a trend that has continued almost since the first edition in 2008: biologics are entering the market at substantially higher rate than small-molecule drugs; combined with the growth of
Download and read the Cold Chain Suppliers Spotlight Directory here.
- Brand Marketing / Communications
- Patient services platforms consolidate with CareMetx acquiring VirMedica
- Novartis and Lilly share the HCPC Compliance Package of the Year award
- Deloitte’s ConvergeHealth platform will link to Vineti to support personalized medicine
- Rare disease patient support